University of Ottawa
Ottawa, Ontario, K1N6N5, Canada
NCT Number: NCT03601663
Physical activity has been shown to reduce the risk of chronic diseases and promote physical and mental health and wellbeing, yet few women are active enough to see these benefits. Wearable activity trackers show promise for helping people increase their physical activity levels by supporting self-monitoring. However, few researchers have examined how providing people with these devices impacts physical activity levels, or motivation for physical activity which is a significant and robust predictor of physical activity. Based on previous research, it is possible that women's physical activity levels would be more likely to increase if they received an autonomy-supportive intervention to enhance motivation in addition to a wearable activity tracker. A pilot, three-armed randomized controlled trial was developed to test this hypothesis and to assess if changes in perceived autonomy-support, basic psychological need satisfaction/thwarting, motivational regulations, wellbeing indicators are associated with changes in physical activity over time.
Looking for future studies?
Notify Me18 year–65 year
Female
Interventional
Not applicable
Ottawa, Ontario, K1N6N5, Canada
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
All participants will need to meet the following inclusion criteria to participate in the intervention:
Participants will receive a copy of the Canadian Physical Activity Guidelines.
Participants will receive a wearable activity tracker (Polar A300).
Participants will receive eight autonomy-supportive weekly emails containing information and activities to help them set goals and make changes to become physically active.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in self-reported physical activity (over the past 7 days) from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in strength and resistance training habits from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Duration of intervention phase (8 weeks).
Change in weekly directly measured levels of physical activity as measured by accelerometers (Polar A300), which will be worn by participants assigned to Group 1 and Group 2 during waking hours for the duration of the intervention.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in perceived autonomy support for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in basic psychological need satisfaction for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in motivational regulations for physical activity from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in basic psychological need thwarting activity from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: : Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in affect from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in vitality affect from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Baseline (week 0), post-intervention (week 9), and follow-up (week 21).
Change in depressive symptoms from baseline to post-intervention, and from post-intervention to follow-up.
Time frame: Post-intervention (week 9).
Frequency of wearable activity tracker usage in general during the intervention phase for participants randomized to Group 1 or Group 2.
Time frame: Duration of recruitment and intervention phases (9 weeks).
The number of eligible participants who enrol in the study out of the number assessed for eligibility.
Time frame: Duration of recruitment and intervention phases (9 weeks).
The number of participants completing all scheduled assessments.
Time frame: Duration of recruitment and intervention phases (9 weeks).
For participants randomized to Group 1, what participants liked, disliked, and would change about the intervention.
Time frame: Baseline (week 0) and post-intervention (week 9).
Change in body mass measured from baseline to post-intervention as determined using a scale (Tanita BWB 800S).
Time frame: Baseline (week 0) and post-intervention (week 9).
Change in body composition from baseline to post-intervention as determined by a scale (Tanita BWB 800S) that uses bioelectrical impedance to assess body composition.
Time frame: Baseline (week 0) and post-intervention (week 9).
Change in waist circumference from baseline to post-intervention as measured using a measuring tape.
Time frame: Baseline (week 0).
Sociodemographic and health information will be collected at baseline to describe the sample. Measures include age, marital status, race, level of education, employment status, household income, number and age of children, self-rated health, medical conditions, menstrual status, smoking history, and weight-related goals.
University of Ottawa
Other
Exploring the Effect of an eHealth Intervention on Women's Physical Activity Behaviour
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03866902
Adiposity, Behavior
Chapel Hill, North Carolina, United States
View Trial DetailsNCT04477577
Behavior, Behavior, Animal
Boston, Massachusetts, United States
View Trial DetailsNCT07496710
Behavior, Body Weight
Alcorcón, Madrid, Spain
View Trial DetailsNCT03191591
Behavior, Behavior, Animal
View Trial Details